BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37437238)

  • 1. Risk of Hypertensive Disorders of Pregnancy in Women Treated With Serotonin-Norepinephrine Reuptake Inhibitors: A Comparative Study Using the EFEMERIS Database.
    Benevent J; Araujo M; Karki S; Delarue-Hurault C; Waser J; Lacroix I; Tebeka S; Damase-Michel C
    J Clin Psychiatry; 2023 Jul; 84(4):. PubMed ID: 37437238
    [No Abstract]   [Full Text] [Related]  

  • 2. Depression and antidepressant treatment in the development of hypertensive disorders of pregnancy: Results from a prospective cohort study.
    Galbally M; Watson SJ; Spigset O
    Aust N Z J Psychiatry; 2023 Apr; 57(4):520-527. PubMed ID: 35786007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SSRI and SNRI use during pregnancy and the risk of persistent pulmonary hypertension of the newborn.
    Bérard A; Sheehy O; Zhao JP; Vinet É; Bernatsky S; Abrahamowicz M
    Br J Clin Pharmacol; 2017 May; 83(5):1126-1133. PubMed ID: 27874994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin-norepinephrine reuptake inhibitor and selective serotonin reuptake inhibitor use and risk of fractures: a new-user cohort study among US adults aged 50 years and older.
    Lanteigne A; Sheu YH; Stürmer T; Pate V; Azrael D; Swanson SA; Miller M
    CNS Drugs; 2015 Mar; 29(3):245-52. PubMed ID: 25708711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal exposure to selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors and risk for persistent pulmonary hypertension of the newborn: a systematic review, meta-analysis, and network meta-analysis.
    Masarwa R; Bar-Oz B; Gorelik E; Reif S; Perlman A; Matok I
    Am J Obstet Gynecol; 2019 Jan; 220(1):57.e1-57.e13. PubMed ID: 30170040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the effects of serotonin-norepinephrine reuptake inhibitors versus selective serotonin reuptake inhibitors on cerebrovascular events.
    Lee YC; Lin CH; Lin MS; Lu Y; Chang CH; Lin JW
    J Clin Psychiatry; 2016 Jan; 77(1):e1-7. PubMed ID: 26845272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective serotonin reuptake inhibitor and selective serotonin and norepinephrine reuptake inhibitor use and risk of fractures in adults: A systematic review and meta-analysis.
    Khanassov V; Hu J; Reeves D; van Marwijk H
    Int J Geriatr Psychiatry; 2018 Dec; 33(12):1688-1708. PubMed ID: 30247774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of serotonin and norepinephrine transporters in antidepressant-induced arterial hypertension: a pharmacoepidemiological-pharmacodynamic study.
    Montastruc JL; Rousseau V; de Canecaude C; Roussin A; Montastruc F
    Eur J Clin Pharmacol; 2020 Sep; 76(9):1321-1327. PubMed ID: 32483650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective serotonin reuptake inhibitor or serotonin-norepinephrine reuptake inhibitors and epidemiological characteristics associated with prenatal diagnosis of congenital heart disease.
    Melov SJ; Shetty PS; Pasupathy D; Kirby A; Sholler GF; Winlaw DS; Alahakoon TI
    Prenat Diagn; 2021 Jan; 41(1):35-42. PubMed ID: 33067884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs) During Pregnancy and the Risk for Autism spectrum disorder (ASD) and Attention deficit hyperactivity disorder (ADHD) in the Offspring: A True Effect or a Bias? A Systematic Review & Meta-Analysis.
    Leshem R; Bar-Oz B; Diav-Citrin O; Gbaly S; Soliman J; Renoux C; Matok I
    Curr Neuropharmacol; 2021; 19(6):896-906. PubMed ID: 33655866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrovascular, Cardiovascular, and Mortality Events in New Users of Selective Serotonin Reuptake Inhibitors and Serotonin Norepinephrine Reuptake Inhibitors: A Propensity Score-Matched Population-Based Study.
    Leong C; Alessi-Severini S; Enns MW; Nie Y; Sareen J; Bolton J; Prior HJ; Chateau D
    J Clin Psychopharmacol; 2017 Jun; 37(3):332-340. PubMed ID: 28383363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of Poor Neonatal Adaptation Syndrome Among Infants Exposed to Second-Generation Atypical Antipsychotics Compared to Antidepressants: Results From the National Pregnancy Registry for Psychiatric Medications.
    Viguera AC; McElheny SA; Caplin PS; Kobylski LA; Rossa ET; Young AV; Gaccione P; Góez-Mogollón L; Freeman MP; Cohen LS
    J Clin Psychiatry; 2023 Jan; 84(1):. PubMed ID: 36602927
    [No Abstract]   [Full Text] [Related]  

  • 13. [TREATMENT OF SEROTONIN AND NOREPINEPHRINE REUPTAKE INHIBITORS (SSRIS AND SNRIS) DURING PREGNANCY AND LACTATION].
    Rozner L; Aisenberg Romano G; Klieger C; Bloch M
    Harefuah; 2023 Feb; 162(2):86-91. PubMed ID: 36916077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal Psychostimulant and Antidepressant Exposure and Risk of Hypertensive Disorders of Pregnancy.
    Newport DJ; Hostetter AL; Juul SH; Porterfield SM; Knight BT; Stowe ZN
    J Clin Psychiatry; 2016 Nov; 77(11):1538-1545. PubMed ID: 28076672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors Are Not Associated With Bleeding or Transfusion in Cardiac Surgical Patients.
    Smith MM; Smith BB; Lahr BD; Nuttall GA; Mauermann WJ; Weister TJ; Dearani JA; Barbara DW
    Anesth Analg; 2018 Jun; 126(6):1859-1866. PubMed ID: 29210786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between selective serotonin and serotonin-noradrenaline reuptake inhibitor therapy and hematuria.
    Sarier M; Demir M; Emek M; Özgen A; Turgut H; Özdemir C
    Nord J Psychiatry; 2023 Jan; 77(1):31-35. PubMed ID: 35243962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective Serotonin Reuptake Inhibitor/Serotonin-Norepinephrine Reuptake Inhibitor Use as a Predictor of a Diagnosis of Restless Legs Syndrome.
    Bailey AL; Makela EH; Asberg K
    J Psychiatr Pract; 2016 Jul; 22(4):263-9. PubMed ID: 27427838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of SSRI and SNRI Antidepressants during Pregnancy: A Population-Based Study from Denmark, Iceland, Norway and Sweden.
    Zoega H; Kieler H; Nørgaard M; Furu K; Valdimarsdottir U; Brandt L; Haglund B
    PLoS One; 2015; 10(12):e0144474. PubMed ID: 26657647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults.
    Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
    Cochrane Database Syst Rev; 2015 Apr; 4(4):CD002919. PubMed ID: 25829028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of vaginal bleeding and postpartum hemorrhage after use of antidepressants in pregnancy: a study from the Norwegian Mother and Child Cohort Study.
    Lupattelli A; Spigset O; Koren G; Nordeng H
    J Clin Psychopharmacol; 2014 Feb; 34(1):143-8. PubMed ID: 24135843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.